Life Sciences

First FDA-Approved ENCELTO Treatment Performed for MacTel
Public Policy First FDA-Approved ENCELTO Treatment Performed for MacTel

Introduction Imagine living with a condition that slowly erases the clarity of central vision, making everyday tasks like reading or recognizing faces increasingly difficult, a reality for individuals diagnosed with idiopathic Macular Telangiectasia Type 2, commonly known as MacTel. This rare

Precision Oncology Innovation – Review
Public Policy Precision Oncology Innovation – Review

Imagine a world where a diagnosis of an aggressive, rare cancer like HER2-mutated non-small cell lung cancer (NSCLC) no longer feels like a dead end, especially for the 2% to 4% of NSCLC patients grappling with this subtype. Often marked by poor prognosis and a high risk of brain metastases,

Superagers' Brains Reveal Clues to Cognitive Resilience
Care Superagers' Brains Reveal Clues to Cognitive Resilience

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with a deep focus on medical technology. With years of experience in the manufacturing of cutting-edge medical devices for diagnostics and treatment, Faisal brings a unique perspective to the fascinating topic of cognitive

Sarepta Faces Gene Therapy Hurdles, Hansa Data Shines
Business Sarepta Faces Gene Therapy Hurdles, Hansa Data Shines

In the dynamic world of biotechnology, gene therapy represents a transformative frontier, promising life-changing treatments for rare genetic disorders like Duchenne muscular dystrophy (DMD). However, with innovation comes complexity, as safety concerns and immune response challenges continue to

Evvy's At-Home Test Revolutionizes Bacterial Vaginosis Care
Care Evvy's At-Home Test Revolutionizes Bacterial Vaginosis Care

I'm thrilled to sit down with Faisal Zain, a renowned healthcare expert with deep expertise in medical technology and innovation. With years of experience in the development of cutting-edge medical devices for diagnostics and treatment, Faisal offers a unique perspective on the evolving

Differentiation Strategies in a Crowded Cell and Gene Therapy Market
Public Policy Differentiation Strategies in a Crowded Cell and Gene Therapy Market

In the evolving world of biotechnology, the cell and gene therapy sector stands out for its innovation and potential, having transitioned from a nascent experimental novelty to a formidable industry force. However, this transition has naturally introduced a new set of challenges, with heightened

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later